These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34686341)

  • 1. RNF8-mediated regulation of Akt promotes lung cancer cell survival and resistance to DNA damage.
    Xu Y; Hu Y; Xu T; Yan K; Zhang T; Li Q; Chang F; Guo X; Peng J; Li M; Zhao M; Zhen H; Xu L; Zheng D; Li L; Shao G
    Cell Rep; 2021 Oct; 37(3):109854. PubMed ID: 34686341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripartite motif-containing 37 (TRIM37) promotes the aggressiveness of non-small-cell lung cancer cells by activating the NF-κB pathway.
    Li Y; Deng L; Zhao X; Li B; Ren D; Yu L; Pan H; Gong Q; Song L; Zhou X; Dai T
    J Pathol; 2018 Nov; 246(3):366-378. PubMed ID: 30043491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric ubiquitin ligases inhibit non-small cell lung cancer via negative modulation of EGFR signaling.
    Zhong D; Ru Y; Wang Q; Zhang J; Zhang J; Wei J; Wu J; Yao L; Li X; Li X
    Cancer Lett; 2015 Apr; 359(1):57-64. PubMed ID: 25573345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymecycline reverses acquired EGFR-TKI resistance in non-small-cell lung cancer by targeting GRB2.
    Chen Y; Wu J; Yan H; Cheng Y; Wang Y; Yang Y; Deng M; Che X; Hou K; Qu X; Zou D; Liu Y; Zhang Y; Hu X
    Pharmacol Res; 2020 Sep; 159():105007. PubMed ID: 32561477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyphyllin I reverses the resistance of osimertinib in non-small cell lung cancer cell through regulation of PI3K/Akt signaling.
    Lai L; Shen Q; Wang Y; Chen L; Lai J; Wu Z; Jiang H
    Toxicol Appl Pharmacol; 2021 May; 419():115518. PubMed ID: 33812963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
    Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
    BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300.
    Jeung YJ; Kim HG; Ahn J; Lee HJ; Lee SB; Won M; Jung CR; Im JY; Kim BK; Park SK; Son MJ; Chung KS
    Biochim Biophys Acta; 2016 Nov; 1863(11):2584-2593. PubMed ID: 27452907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VAOS, a novel vanadyl complexes of alginate saccharides, inducing apoptosis via activation of AKT-dependent ROS production in NSCLC.
    Zhou L; Yi Y; Yuan Q; Zhang J; Li Y; Wang P; Xu M; Xie S
    Free Radic Biol Med; 2018 Dec; 129():177-185. PubMed ID: 30223019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways.
    Hao P; Huang Y; Peng J; Yu J; Guo X; Bao F; Dian Z; An S; Xu TR
    Exp Cell Res; 2021 Jun; 403(2):112615. PubMed ID: 33894221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
    Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
    Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling.
    Lin PL; Wu TC; Wu DW; Wang L; Chen CY; Lee H
    Eur J Cancer; 2017 Nov; 85():95-105. PubMed ID: 28892778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
    Zeng C; Wu Q; Wang J; Yao B; Ma L; Yang Z; Li J; Liu B
    Free Radic Biol Med; 2016 Dec; 101():236-248. PubMed ID: 27989748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8.
    Singh AN; Oehler J; Torrecilla I; Kilgas S; Li S; Vaz B; Guérillon C; Fielden J; Hernandez-Carralero E; Cabrera E; Tullis ID; Meerang M; Barber PR; Freire R; Parsons J; Vojnovic B; Kiltie AE; Mailand N; Ramadan K
    EMBO J; 2019 Oct; 38(21):e102361. PubMed ID: 31613024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DNA Damage Transducer RNF8 Facilitates Cancer Chemoresistance and Progression through Twist Activation.
    Lee HJ; Li CF; Ruan D; Powers S; Thompson PA; Frohman MA; Chan CH
    Mol Cell; 2016 Sep; 63(6):1021-33. PubMed ID: 27618486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF8 induces autophagy and reduces inflammation by promoting AKT degradation via ubiquitination in ulcerative colitis mice.
    Zhu Y; Shi Y; Ke X; Xuan L; Ma Z
    J Biochem; 2020 Nov; 168(5):445-453. PubMed ID: 32597970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between long non-coding RNA PCAT-1 expression and gefitinib resistance in non-small-cell lung cancer cells.
    Wang S; Liu C; Lei Q; Wu Z; Miao X; Zhu D; Yang X; Li N; Tang M; Chen Y; Wang W
    Respir Res; 2021 May; 22(1):146. PubMed ID: 33980216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
    He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
    Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.